Condition

Malignant Neoplasms

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5
Recruiting1
Common interventions9
Lead sponsors shown4
Advertisement

Clinical trials

5 shown
A Study of DEG6498 in Participants With Solid TumorsNCT07244835 · 2025-11-13
RECRUITING
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsNCT05538130 · 2022-11-30
ACTIVE_NOT_RECRUITING
CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsNCT04660929 · 2021-02-02
UNKNOWN
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain InvolvementNCT04543188 · 2021-01-08
TERMINATED
The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor PatientsNCT04202848 · 2019-12-20
UNKNOWN

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

binimetinib1midazolam1

Trial status mix

UNKNOWN2
ACTIVE_NOT_RECRUITING1
RECRUITING1
TERMINATED1

Phase mix

PHASE14

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.